According to a recent Markets and Markets report, the global bioburden testing market is expected to reach $565.6 Million by 2018, and Pacific BioLabs has been listed as one of ten key players in this global bioburden market.
According to a recent Markets and Markets report, the global bioburden testing market is expected to reach $565.6 Million by 2018, and Pacific BioLabs has been listed as one of ten key players in this global bioburden market.